Markets:

Overview

News

Currencies

International

Treasuries

Bristol-Myers Squibb (NY:BMY)

59.72 -0.41 (-0.68%)

Streaming Delayed Price Updated: 10:46 AM EDT, Mar 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

87 88 Next >

Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights ↗

April 26, 2024

Via Benzinga

Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review ↗

April 26, 2024

Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.

Via Investor's Business Daily

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

April 26, 2024

From Bristol Myers Squibb

Via Business Wire

Why Bristol Myers Squibb Stock Is Sinking Today ↗

April 25, 2024

Investors didn't like the biopharmaceutical company's updated guidance.

Via The Motley Fool

A Closer Look at Bristol-Myers Squibb's Options Market Dynamics ↗

April 19, 2024

Via Benzinga

Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points ↗

April 26, 2024

Via Benzinga

Topics Stocks

Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results ↗

April 25, 2024

Via Benzinga

Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions ↗

April 25, 2024

Discover Bristol Myers Squibb's impressive first-quarter performance, with revenues exceeding expectations driven by key products like Eliquis and Reblozyl. Despite challenges, the company aims for...

Via Benzinga

PLTR Stock: Palantir Beefs Up Healthcare AI Work Through Parexel Deal ↗

April 25, 2024

Palantir stock is slipping on Thursday even as PLTR traders learn of a new contract between the data company and Parexel.

Via InvestorPlace

Topics Artificial Intelligence

BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024 ↗

April 25, 2024

BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 25, 2024

Via Benzinga

Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts ↗

April 25, 2024

Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024.

Via InvestorPlace

Topics Workforce

Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript ↗

April 25, 2024

BMY earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Is Bristol Myers Squibb Stock a Millionaire Maker? ↗

April 25, 2024

Bristol Myers Squibb faces some challenges, but there could be light at the end of the tunnel for long-term investors.

Via The Motley Fool

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market ↗

April 25, 2024

The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.

Via Investor's Business Daily

AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags ↗

April 25, 2024

AstraZeneca soundly topped analyst views while Sanofi narrowed its losses. Both stocks surged in early trade.

Via Investor's Business Daily

Bristol Myers Squibb Reports First Quarter Financial Results for 2024

April 25, 2024

From Bristol Myers Squibb

Via Business Wire

Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook ↗

April 23, 2024

Discover Novartis' Q1 EPS soars 17% to $1.80, surpassing estimates. Sales hit $11.83B, up 10%. Entresto sales surge 36%, Cosentyx up 25%. CEO Vas Narasimhan bullish on mid & long-term growth.

Via Benzinga

US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst ↗

April 25, 2024

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NASDAQ:META)

Via Benzinga

5 Crash-Proof Stocks to Buy Immediately ↗

April 22, 2024

We may not be headed to a full-blown crisis, but savvy investors should protect their portfolios now with these crash-proof stocks.

Via InvestorPlace

Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster

April 22, 2024

From Bristol Myers Squibb

Via Business Wire

3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations ↗

April 20, 2024

These stocks pay between 3.2% and 6.7% in dividends.

Via The Motley Fool

These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher? ↗

April 19, 2024

Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.

Via InvestorPlace

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week ↗

April 21, 2024

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

Via Benzinga

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies ↗

April 19, 2024

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel

Via Benzinga

Got $500? 3 Healthcare Stocks to Buy and Hold Forever ↗

April 19, 2024

Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.

Via The Motley Fool

Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)

April 18, 2024

Via AB Newswire

Topics Economy

3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500 ↗

April 17, 2024

If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.

Via InvestorPlace

Topics Stocks

2 High-Yield Dividend Stocks to Buy and Hold for 10 Years ↗

April 17, 2024

These income stocks look like good options at current levels.

Via The Motley Fool

3 Pharma Stocks That Are Money-Printing Machines in 2024 ↗

April 15, 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

Via InvestorPlace

Topics Economy

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

87 88 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.